Biobanking Market Share, Growth and Trends Analysis by Emergen Research

The global biobanking market size is expected to reach USD 67.90 Billion in 2030 and register a revenue CAGR of 8.6% over the forecast period, according to latest analysis by Emergen Research.

Increasing genomic research activities and investment in R&D by major companies is driving global biobanking market revenue growth. Surge in research activities of regenerative medicines, stem cell therapeutics, and cell and gene therapy is also driving revenue growth of the global market.

Read More @ https://www.emergenresearch.com/industry-report/biobanking-market

Biobanking market revenue growth is also driven by increase in application of bio-banked samples. Biobanks focusing on plants, animals, and microbes are evolving rapidly. Different types of biobanks are gaining traction, such as disease-centric biobanks, population-based banks, DNA/RNA banks, genetic banks, tissue banks, blood banks, virtual biobanks, stem cell banks, microbiome banks, and others, which is driving market revenue growth.

Biobanks enable access to large pool of high-quality samples and associated data. These are reliable hubs for storage and processing of samples from clinical trials and other sources. Biobanks help to achieve important conditions for achieving reproducible research results.